Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a

This study was designed to investigate the hemodynamic effect of rolipram, a phosphodiesterase type 4 (PDE4) inhibitor, in normal rat hearts both in vivo and in vitro and its underlying mechanism. The pressure-volume loop, isolated heart, and Ca2+ transients triggered by field stimulation or caffein...

Full description

Bibliographic Details
Main Authors: Huili Huang, Ming Xie, Li Gao, Wenhui Zhang, Xiaojia Zhu, Yuwei Wang, Wei Li, Rongrong Wang, Kesu Chen, Mohamed Boutjdir, Long Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00221/full